French Company Terminates Production of HIV Drug for Infants

(9 June 10 - RV) Officials from an international group that helps ensure patients get access to HIV drugs has warned that Bristol-Myers Squibb Company’s plans to close a factory in France could leave thousands of babies without life saving treatment for the virus that causes AIDS.

The UN affiliated group UNITAID is urging Bristol-Myers to take measures to ensure that babies continue to have access to the low-dose drug. The drug will not become available again until next April.

Dr Rachelle Child is the director of operations for UNITAID. She told us more about how many children will be affected….